Enzo |
BML-P157-0001 |
Shp 1 & 2 substrate
|
1mg |
|
|
Enzo |
BML-P156-0001 |
PKC zeta substrate
|
1mg |
|
|
Enzo |
BML-P155-0500 |
[Ser159] PKC ε (149-164)
|
0.5mg |
|
|
Enzo |
BML-P153-0001 |
Protein tyrosine phosphatase substrate
|
1mg |
|
|
Enzo |
BML-P154-0001 |
PKC delta substrate
|
1mg |
|
|
Enzo |
BML-P149-0001 |
Crosstide
|
1mg |
|
|
Enzo |
BML-P150-0500 |
Protein kinase C (19-36)
|
0.5mg |
|
|
Enzo |
BML-P151-0001 |
GSK 3 substrate
|
1mg |
|
|
Enzo |
BML-P152-0001 |
Protein phosphatase 2 substrate
|
1mg |
|
|
Enzo |
BML-P147-0001 |
Casein kinase II peptide substrate
|
1mg |
|
|
Enzo |
BML-P148-0001 |
IκB kinase substrate (biotinylated)
|
1mg |
|
|
Enzo |
BML-P146-0001 |
Casein kinase I peptide substrate
|
1mg |
|
|
Enzo |
BML-P144-0001 |
Ribosomal protein S6 (rat) (229-239)
|
1mg |
|
|
Enzo |
BML-P145-0001 |
Cathepsin D & E substrate (fluorogenic)
|
1mg |
|
|
Enzo |
BML-P142-0020 |
Z-GPR-AMC
|
20mg |
|
|
Enzo |
BML-P141-0025 |
Suc-AAPF-pNA
|
25mg |
|
|
Enzo |
BML-P142-0005 |
Z-GPR-AMC
|
5mg |
|
|
Enzo |
BML-P139-0050 |
OMNICATHEPSIN fluorogenic substrate
|
50mg |
|
|
Enzo |
BML-P138-0025 |
Z-RR-pNA
|
25mg |
|
|
Enzo |
BML-P139-0010 |
OMNICATHEPSIN fluorogenic substrate
|
10mg |
|
|
Enzo |
BML-P137-0050 |
Z-RR-AMC
|
50mg |
|
|
Enzo |
BML-P136-0025 |
H-Arg-pNA . 2HCl
|
25mg |
|
|
Enzo |
BML-P137-0010 |
Z-RR-AMC
|
10mg |
|
|
Enzo |
BML-P133-0005 |
Ac-IEPD-pNA
|
5mg |
|
|
Enzo |
BML-P134-0005 |
Ac-IEPD-AMC
|
5mg |
|
|
Enzo |
BML-P135-0025 |
H-Arg-AMC . 2HCl
|
25mg |
|
|
Enzo |
BML-P132-0500 |
TACE substrate (fluorogenic)
|
0.5mg |
|
|
Enzo |
BML-P131-0001 |
MMP substrate alpha (fluorogenic)
|
1mg |
|
|
Enzo |
BML-P129-0001 |
Akt substrate
|
1mg |
|
|
Enzo |
BML-P128-0001 |
MMP substrate (fluorogenic)
|
1mg |
|
|
Enzo |
BML-P127-0001 |
OMNIMMP fluorogenic control
|
1mg |
|
|
Enzo |
BML-P125-0005 |
MMP substrate (chromogenic)
|
5mg |
|
|
Enzo |
BML-P126-0001 |
OMNIMMP fluorogenic substrate
|
1mg |
|
|
Enzo |
BML-P124-0001 |
ERK1 / ERK2 (172-190)
|
1mg |
|
|
Enzo |
BML-P123-0001 |
Tyrosine hydroxylase (rat) (24-33)
|
1mg |
|
|
Enzo |
BML-P121-0001 |
EGF receptor (661-681)
|
1mg |
|
|
Enzo |
BML-P122-0001 |
Myelin basic protein (95-98) S5 peptide
|
1mg |
|
|
Enzo |
BML-P101-0001 |
Autocamtide 2
|
1mg |
|
|
Enzo |
BML-P102-0001 |
Syntide 2
|
1mg |
|
|
Enzo |
BML-P103-0001 |
Casein kinase 2 beta (198-215)
|
1mg |
|
|
Enzo |
BML-P104-0500 |
CSH103 substrate
|
500µg |
|
|
Enzo |
BML-P106-0001 |
H1-7
|
1mg |
|
|
Enzo |
BML-P107-0001 |
Kemptide
|
1mg |
|
|
Enzo |
BML-P108-0001 |
Malantide
|
1mg |
|
|
Enzo |
BML-P109-0001 |
EGF receptor (651-658)
|
1mg |
|
|
Enzo |
BML-P120-0005 |
Ac-Leu-Leu-Nle-al
|
5mg |
|
|
Enzo |
BML-P120-0025 |
Ac-Leu-Leu-Nle-al
|
25mg |
|
|
Enzo |
BML-P115-0001 |
MLCK substrate (skeletal muscle)
|
1mg |
|
|
Enzo |
BML-P118-0500 |
(Ala97)-RII (81-99)
|
0.5mg |
|
|
Enzo |
BML-P114-0001 |
MLCK substrate (skeletal and smooth muscle)
|
1mg |
|
|